Top 5 Upgrades:Oppenheimer analyst Leland Gershell upgraded BioMarin to Outperform from Perform with a price target of $110, up from $92. Entering 2023, the market's increasing recognition of BioMarin...
Source LinkTop 5 Upgrades:Oppenheimer analyst Leland Gershell upgraded BioMarin to Outperform from Perform with a price target of $110, up from $92. Entering 2023, the market's increasing recognition of BioMarin...
Source Link
Comments